Home Depot Posts Mixed Q4 Earnings, Hikes Dividend By 10%, Forecasts Decline In FY23 EPS

Signal Profit

Home Depot Posts Mixed Q4 Earnings, Hikes Dividend By 10%, Forecasts Decline In FY23 EPS

Feb 21st, 2023 9:54 EST

Don't miss real-time alerts on your stocks - join Benzinga Pro for free! Try the tool that will help you invest smarter, faster, and better.

This article Home Depot Posts Mixed Q4 Earnings, Hikes Dividend By 10%, Forecasts Decline In FY23 EPS originally appeared on Benzinga.com

Link to Source

You must be logged in to post a comment.

Related Recent Publications

#Third-Party Article

'We were arrogant': RH’s CEO says he raised already expensive furniture prices too much on shoppers

05/26/2023 07:50

#Third-Party Article

Why retail stocks look terrifying: Morning Brief

05/19/2023 09:57

#Dividends

#Financial Data

The Home Depot Declares First Quarter Dividend of $2.09

05/18/2023 16:15

#Financial Data

#Third-Party Article

Stock futures mixed amid debt debate, Walmart earnings: Stock market news today

05/18/2023 08:39

#New Partnership

#New Program

The Home Depot Partners with Army & Air Force Exchange Service to Offer Tax-Free Major Appliances

05/18/2023 08:00

#Third-Party Article

GE, Ikea, Home Depot defeat University of California bid for light bulb import bans

05/16/2023 15:42

#Third-Party Article

Stock futures edge lower ahead of key debt-ceiling talks: Stock market news today

05/16/2023 08:53

05/16/2023 06:00

Home Depot Q1 earnings preview: Here's what to expect

05/15/2023 16:47

#Third-Party Article

Stocks waver amid debt-limit hopes: Stock market news today

05/15/2023 09:33

You must be logged in to post a comment.

Email newsletter

Receive the latest stock news and signals

Home Depot Posts Mixed Q4 Earnings, Hikes Dividend By 10%, Forecasts Decline In FY23 EPS

Related Recent Publications

Email newsletter

Trending News

Iovance Biotherapeutics Announces U.S. Food and Drug Administration Acceptance of the Biologics License Application of Lifileucel for the Treatment of Advanced Melanoma

SILVERCORP DECLARES SEMI-ANNUAL DIVIDEND OF US$0.0125 PER SHARE

Halo Collective Provides Update on Status of Financial Statements

Molecular Templates to Present on Phase I Dose Escalation Study of MT-6402 at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting

US Investors May Now Have Trading Access for Genius Group Shares on Upstream through US Broker Dealer

Most Read News

New England Journal of Medicine Publishes Results from Phase 3 Induction and Maintenance Programs Evaluating Upadacitinib (RINVOQ®) in Crohn's Disease

Shareholder Alert: Ademi LLP investigates whether CohBar, Inc. has obtained a Fair Price in its transaction with Morphogenesis, Inc.

Avante Announces Private Placement Closing

Tools

Learn

Account

Company

Partnerships

Create account

Sign In

Sign In